Ann Tucker
- Feb 17
- 1 min read

SAMHSA to Issue Interim Measures If Buprenorphine Rule Delayed

SAMHSA (2/10) -- HHS has says that if the SAMHSA is unable to complete rulemaking that allows providers in opioid treatment programs to continue to initiate buprenorphine following a telehealth visit before the May 11 end of the public health emergency, SAMHSA will enact interim measures to bridge any gap that may result after the PHE ends. Cont.

Recent Posts

See All

Bill Introduced to Establish Felony Murder Charges for Fentanyl Dealers

U.S. Senate (2/14) -- Senate Republicans have introduced a bill to charge illicit fentanyl drug dealers with murder. The Felony Murder for Deadly Fentanyl Distribution Act would add the distribution o

More Than 1 in 9 U.S. Adults With Co-Occurring Mental Illness and Substance Use Disorders Are Arrest

Lawmakers Urge Biden to Elevate ONDCP Director to Cabinet-Level

U.S. House (2/01) -- Recently, a bipartisan group of 55 lawmakers wrote a letter to President Joe Biden asking that the Director of the White House Office of National Drug Control Policy (ONDCP) be re

SAMHSA to Issue Interim Measures If Buprenorphine Rule Delayed

Recent Posts

Subscribe to the CLASPP Newsletter

Email:

Phone: